See more : The a2 Milk Company Limited (A2M.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Pegavision Corporation (6491.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pegavision Corporation, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- LifeTech Scientific Corporation (1302.HK) Income Statement Analysis – Financial Results
- Toyota Boshoku Corporation (TDBOF) Income Statement Analysis – Financial Results
- AKG Exim Limited (AKG.NS) Income Statement Analysis – Financial Results
- Greenhawk Resources Inc. (GRHK.CN) Income Statement Analysis – Financial Results
- Fairfax India Holdings Corporation (FFXDF) Income Statement Analysis – Financial Results
Pegavision Corporation (6491.TW)
About Pegavision Corporation
Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. The company was incorporated in 2009 and is based in Taoyuan City, Taiwan. Pegavision Corporation is a subsidiary of Pegatron Corp.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.79B | 6.32B | 5.60B | 3.98B | 3.36B | 3.13B | 2.18B | 1.66B | 1.31B | 920.94M | 589.32M | 229.73M |
Cost of Revenue | 3.12B | 3.01B | 2.63B | 1.97B | 1.86B | 1.53B | 1.13B | 819.17M | 638.11M | 478.45M | 276.39M | 120.13M |
Gross Profit | 3.67B | 3.32B | 2.96B | 2.00B | 1.49B | 1.61B | 1.05B | 840.17M | 669.51M | 442.49M | 312.93M | 109.61M |
Gross Profit Ratio | 54.03% | 52.45% | 52.98% | 50.39% | 44.50% | 51.25% | 48.10% | 50.63% | 51.20% | 48.05% | 53.10% | 47.71% |
Research & Development | 592.40M | 575.93M | 546.64M | 374.46M | 279.80M | 237.96M | 230.40M | 224.59M | 200.87M | 138.61M | 110.96M | 73.27M |
General & Administrative | 431.74M | 371.08M | 321.54M | 218.09M | 195.05M | 186.26M | 137.14M | 100.65M | 91.89M | 67.36M | 37.43M | 29.06M |
Selling & Marketing | 622.84M | 555.43M | 627.07M | 552.74M | 427.76M | 387.28M | 325.30M | 278.07M | 239.94M | 177.11M | 134.49M | 55.86M |
SG&A | 1.05B | 926.50M | 948.61M | 770.82M | 622.81M | 573.54M | 462.43M | 378.72M | 331.83M | 244.47M | 171.92M | 84.91M |
Other Expenses | 0.00 | 11.30M | -16.07M | -11.69M | -9.10M | -20.69M | 12.71M | 1.40M | 21.13M | 13.91M | 18.34M | 0.00 |
Operating Expenses | 1.69B | 1.50B | 1.50B | 1.15B | 902.61M | 811.50M | 692.83M | 603.30M | 532.69M | 383.07M | 282.88M | 142.25M |
Cost & Expenses | 4.81B | 4.51B | 4.13B | 3.12B | 2.76B | 2.34B | 1.83B | 1.42B | 1.17B | 861.52M | 559.28M | 262.38M |
Interest Income | 29.92M | 8.63M | 4.47M | 4.81M | 3.84M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.28M |
Interest Expense | 45.53M | 22.53M | 4.46M | 3.96M | 22.16M | 9.92M | 2.89M | 3.43M | 4.58M | 4.37M | 3.74M | 0.00 |
Depreciation & Amortization | 936.94M | 932.71M | 656.56M | 609.02M | 687.07M | 514.62M | 267.80M | 244.23M | 207.61M | 129.27M | 81.66M | 35.24M |
EBITDA | 2.96B | 2.77B | 2.11B | 1.46B | 1.27B | 1.29B | 637.28M | 482.49M | 365.55M | 202.60M | 130.04M | -13.34M |
EBITDA Ratio | 43.61% | 43.75% | 37.78% | 36.73% | 37.80% | 41.11% | 29.20% | 29.08% | 27.96% | 22.00% | 22.07% | -5.80% |
Operating Income | 1.98B | 1.83B | 1.46B | 852.37M | 581.32M | 773.17M | 369.47M | 238.26M | 157.94M | 73.33M | 48.38M | -48.58M |
Operating Income Ratio | 29.18% | 29.00% | 26.05% | 21.42% | 17.33% | 24.68% | 16.93% | 14.36% | 12.08% | 7.96% | 8.21% | -21.14% |
Total Other Income/Expenses | -2.47M | -15.67M | -25.12M | -10.83M | -29.57M | -33.40M | 9.82M | -2.03M | 16.54M | 9.55M | 14.60M | 13.65M |
Income Before Tax | 1.98B | 1.82B | 1.44B | 844.85M | 560.86M | 760.46M | 366.58M | 234.83M | 153.35M | 68.96M | 44.64M | -34.93M |
Income Before Tax Ratio | 29.14% | 28.75% | 25.81% | 21.24% | 16.72% | 24.28% | 16.80% | 14.15% | 11.73% | 7.49% | 7.58% | -15.20% |
Income Tax Expense | 300.71M | 271.94M | 195.50M | 129.50M | 85.36M | 219.30M | 63.68M | 47.94M | 26.24M | 4.37M | 3.74M | 0.00 |
Net Income | 1.66B | 1.54B | 1.25B | 715.36M | 475.49M | 541.16M | 302.91M | 186.89M | 127.11M | 68.96M | 44.64M | -34.93M |
Net Income Ratio | 24.39% | 24.40% | 22.32% | 17.98% | 14.17% | 17.27% | 13.88% | 11.26% | 9.72% | 7.49% | 7.58% | -15.20% |
EPS | 22.83 | 21.75 | 17.61 | 10.09 | 7.52 | 8.90 | 4.99 | 3.07 | 2.09 | 1.27 | 1.05 | -1.25 |
EPS Diluted | 22.61 | 21.56 | 17.49 | 10.03 | 7.46 | 8.82 | 4.96 | 3.05 | 2.08 | 1.27 | 1.05 | -1.25 |
Weighted Avg Shares Out | 72.54M | 70.91M | 70.91M | 70.91M | 63.25M | 60.78M | 60.78M | 60.78M | 60.78M | 54.15M | 42.66M | 27.87M |
Weighted Avg Shares Out (Dil) | 73.22M | 71.52M | 71.38M | 71.34M | 63.72M | 61.38M | 61.10M | 61.26M | 61.03M | 54.21M | 42.71M | 27.87M |
Source: https://incomestatements.info
Category: Stock Reports